Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PRDA.JK
Strong BuyFull HousePT Prodia Widyahusada Tbk · Healthcare · Indonesia · $142M · Avg Vol: $148K/d
100
StockRankGet insider-trade alerts
Q
80
V
87
M
78
P/E (TTM)
11.9x
ROE
9.2%
D/E
0.0x
Dividend %
5.8%
COMPANY DESCRIPTION
PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services.
FINANCIAL SUMMARY (IDR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2T | 2.2T | 2.3T | 2.3T | 1.5% | 2.4T | 2.4T | 2.5T | 5.5% |
| EPS (IDR) | 396.42 | 277.20 | 288.21 | 227.25 | -16.9% | 238.57 | 249.84 | 288.91 | 12.8% |
| Shares | 937.5M | 937.5M | 937.5M | 889.8M | -5.1% | 889.8M | — | — | — |
| Debt | 31.5B | 31.4B | 30.3B | 20.9B | -12.9% | 21.0B | — | — | — |
| Equity | 2.3T | 2.4T | 2.5T | 2.4T | 1.2% | — | — | — | — |
| Op CF | 459.8B | 411.3B | 476.6B | 424.1B | -2.7% | 455.0B | — | — | — |
| Inv CF | 65.4B | -244.3B | -299.8B | 54.9B | — | — | — | — | — |
| Fin CF | -434.6B | -322.5B | -278.0B | -331.7B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+19.6%
SMA 50SMA 200
Close
$0.1605
RSI (14)
80.6
52W High
$0.168
From 52W High
1.0%
SCORE BREAKDOWN
Quality
80
ROIC
10.7%72.9
ROE
9.2%67.7
GP/Assets
50.8%87.0
Op. Margin
11.3%66.1
FCF/Assets
9.4%85.6
Piotroski
783.9
Int. Cover
50.0x89.2
D/E Ratio
0.01x85.4
Current Ratio
5.35x73.9
Value
87
P/E (TTM)
11.9x84.2
EV/EBITDA
5.1x92.5
P/FCF
9.8x84.2
P/B
1.1x83.7
P/S
1.1x83.0
Div Yield
5.8%94.2
Momentum
78
52W High %
96%94.7
RS 6M
45%89.8
SMA 50/200
1.05x66.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-4%34.0
FUNDAMENTALS
Market Cap
$142M
P/E (Forward)
9.8x
Gross Margin
57.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PRDA.JK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PRDA.JK | PT Prodia Widyahusada Tbk(you) | $142M | 100 | Strong Buy |
| MARK.JK | PT Mark Dynamics Indonesia Tbk | $233M | 100 | Strong Buy |
| KLBF.JK | PT Kalbe Farma Tbk. | $2.0B | 94 | Strong Buy |
| MIKA.JK | PT Mitra Keluarga Karyasehat Tbk | $1.5B | 84 | Strong Buy |
| KAEF.JK | PT Kimia Farma Tbk | $150M | 35 | Hold |
| SAME.JK | PT Sarana Meditama Metropolitan Tbk | $308M | 46 | Hold |
| SILO.JK | PT Siloam International Hospitals Tbk | $1.6B | 78 | Buy |
| LPKR.JK | PT Lippo Karawaci Tbk | $249M | 40 | Hold |
| SOHO.JK | PT Soho Global Health Tbk | $1.2B | 57 | Hold |
| HEAL.JK | PT Medikaloka Hermina Tbk | $589M | 35 | Sell |
Peer medians: ROE 7.3% · P/E 20.2x · Gross margin 35.8%